Latest Cancer News

Read the latest cancer news from the National Cancer Institute. The UNM Comprehensive Cancer Center is one of only 49 NCI-designated comprehensive cancer centers bringing leading, national cancer care to New Mexico.

Pediatricians’ Offices Can Help Parents Quit Smoking, Study Shows

Researchers tested a program that trains pediatricians’ offices to provide smoking cessation treatment to parents during visits with their child’s doctor. The approach is intended to reach adults who are motivated to quit to protect their child’s health.

To Treat Pancreatic Cancer, Mouse Study Suggests Altering Tumor Microbiome

In people with pancreatic cancer, the makeup of bacteria that populate their tumors could predict how long they live, results from a new study suggest. Experiments in mice suggested that altering the tumor microbiome could play a role in treatment.

For Some Women with Breast Cancer, Cost Influences Decisions about Surgery

In a survey of nearly 600 breast cancer survivors, researchers found that the cost of care factored into the decisions the women made about what type of surgery to get. Many women also reported never discussing costs with their physicians.

Building on Success, Maximizing Opportunities: NCI’s Annual Plan & Budget Proposal

NCI Acting Director Douglas Lowy, M.D., discusses the institute’s Annual Plan & Budget Proposal for Fiscal Year 2021, which includes the institute’s professional judgement on the funding required to make the most rapid progress against cancer.

Altering Diet Enhances Response to Cancer Treatments in Mice

A new NCI-supported study showed that altering cancer cell metabolism by feeding mice a diet very low in the nutrient methionine improved the ability of chemotherapy and radiation therapy to shrink tumors.

Pembrolizumab Approved for Some Patients with Advanced Esophageal Cancer

FDA has approved the immunotherapy drug pembrolizumab (Keytruda) to treat some patients with advanced esophageal cancer. Patients must have certain levels of the protein PD-L1 on their tumors, as determined by an FDA-approved test.

Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases

An NCI-funded clinical trial is testing the immunotherapy drug nivolumab (Opdivo) in people who have advanced cancer and an autoimmune disease, such as rheumatoid arthritis, lupus, or multiple sclerosis, who are often excluded from such trials.

Newly Discovered ‘Don’t Eat Me’ Signal May be a Target for Cancer Immunotherapy

Researchers have identified a protein called CD24 that may be a new target for cancer immunotherapy. The protein is a ‘don’t eat me’ signal that prevents immune cells called macrophages from engulfing and eating cells.

The Childhood Cancer Data Initiative: Transforming the Pediatric Cancer Landscape through Sharing Data

To prepare for the proposed Childhood Cancer Data Initiative, NCI sponsored a 3-day symposium that brought together pediatric cancer researchers, advocates, and other stakeholders.

MGUS to Myeloma: Study Suggests Risk of Progression Can Change

A person’s risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to the blood cancer multiple myeloma can change over time, according to a new study.